VisMederi will be attending the World Vaccine Congress Europe 2024, taking place from October 28th to 31st at Fira de Barcelona, Montjuïc. The significance of this event brings together leading minds from the life sciences and public health fields to discuss the most recent advances in vaccination research and development.
VisMederi will be demonstrating its wide vaccine evaluation expertise at Booth 44, including bioanalytical method development, immunogenicity research, and contributions to worldwide clinical trials. Our team will be available to meet with participants, share thoughts, and talk about future collaborations for developing global public health projects.
We are also pleased to announce that our Chief Development Officer, Alessandro Manenti, will be a featured speaker at the congress. His presentation, titled “Vaccine Assessment and Serological Assay,” will provide a comprehensive examination at the methods and breakthroughs that will shape the future of vaccine research. This workshop will offer attendees with useful insights into the critical role which serological and functional assays play in the development and validation of new vaccine candidates.
VisMederi looks forward to this event as a forum for expanding its partnerships with the scientific community and contribute to relevant conversations on challenges and potential customers in vaccine development.
We invite all attendees to visit us at Booth 44 and meet with our experts to learn more about VisMederi’s commitment to improving global health via scientific excellence and innovation.
Event details:
Date: October 28–31, 2024.
Fira de Barcelona can be found at Montjuïc in Barcelona, Spain.
VisMederi Booth: 44.
